Showing results (531-540 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|November 12, 2005
Sex differences in the subjective tolerability of antipsychotic drugsCorrado Barbui, Michela Nosè, Jonathan Bindman, et al.Journal of Clinical Psychopharmacology|November 12, 2005
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patientsManabu Saito, Norio Yasui-Furukori, Taku Nakagami, et al.Journal of Clinical Psychopharmacology|November 12, 2005
Antidepressants, warfarin, and the risk of hemorrhagePaul A Kurdyak, David N Juurlink, Alexander Kopp, et al.Journal of Clinical Psychopharmacology|November 12, 2005
Effects of age and sex on olanzapine plasma concentrationsUlrike Weiss, Josef Marksteiner, Georg Kemmler, et al.Journal of Clinical Psychopharmacology|November 12, 2005
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trialJeffrey A MattesJournal of Clinical Psychopharmacology|November 12, 2005
Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trialStuart N Seidman, Marissa Miyazaki, Steven P RooseJournal of Clinical Psychopharmacology|November 12, 2005
Fluvoxamine affects sildenafil kinetics and dynamicsChristiane Hesse, Heike Siedler, Jürgen Burhenne, et al.Journal of Clinical Psychopharmacology|November 12, 2005
Increased cholesterol levels after paroxetine treatment in patients with panic disorderEui Jung Kim, Bum-Hee YuJournal of Clinical Psychopharmacology|November 12, 2005
Characterizations of long-term anxiolytic benzodiazepine prescriptions in veteran patientsJohn A Hermos, Melissa M Young, Elizabeth V Lawler, et al.Journal of Clinical Psychopharmacology|October 11, 2018
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and SuggestionsSusan Schenk, David NewcombePageof 332